Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure

被引:1400
作者
Green, CP
Porter, CB
Bresnahan, DR
Spertus, JA
机构
[1] Univ Missouri, Mid Amer Heart Inst, Dept Med, Cardiol Sect, Kansas City, MO 64111 USA
[2] St Lukes Hosp, Mid Amer Heart Inst, Kansas City, MO 64111 USA
关键词
D O I
10.1016/S0735-1097(00)00531-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To create a valid, sensitive, disease-specific health status measure for patients with congestive heart failure (CHF). BACKGROUND Quantifying health status is becoming increasingly important for CHF. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a new, self-administered, 23-item questionnaire that quantifies physical limitations, symptoms, self-efficacy, social interference and quality of life. METHODS To establish the performance characteristics of the KCCQ, two distinct patient cohorts were recruited: 70 stable and 59 decompensated CHF patients with ejection fractions of <40. Upon entry into the study, patients were administered the KCCQ, the Minnesota Living with Heart Failure Questionnaire and the Short Form-36 (SF-36). Questionnaires were repeated three months later. RESULTS Convergent validity of each KCCQ domain was documented by comparison with available criterion standards (r = 0.46 to 0.74; p < 0.001 for all). Among those with stable CHF who remained stable by predefined criteria (n = 39), minimal changes in KCCQ domains were detected over three months of observation (mean change = 0.8 to 4.0 points, p = NS for all). In contrast, large changes in score were observed among patients whose decompensated CHF improved three months later (n = 39; mean change = 15.4 to 40.4 points, p < 0.01 for all). The sensitivity of the KCCQ was substantially greater than that of the Minnesota Living with Heart Failure and the SF-36 questionnaires. CONCLUSIONS The KCCQ is a valid, reliable and responsive health status measure for patients with CHF and may serve as a clinically meaningful outcome in cardiovascular research, patient management and quality assessment. (J Am Coll Cardiol 2000;35:1245-55) (C) 2000 by the American College of Cardiology.
引用
收藏
页码:1245 / 1255
页数:11
相关论文
共 23 条
[1]   PERFORMANCE OF A 5-ITEM MENTAL-HEALTH SCREENING-TEST [J].
BERWICK, DM ;
MURPHY, JM ;
GOLDMAN, PA ;
WARE, JE ;
BARSKY, AJ ;
WEINSTEIN, MC .
MEDICAL CARE, 1991, 29 (02) :169-176
[2]   Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure [J].
Bristow, MR ;
Gilbert, EM ;
Abraham, WT ;
Adams, KF ;
Fowler, MB ;
Hershberger, RE ;
Kubo, SH ;
Narahara, KA ;
Ingersoll, H ;
Krueger, S ;
Young, S ;
Shusterman, N .
CIRCULATION, 1996, 94 (11) :2807-2816
[3]   Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure [J].
Colucci, WS ;
Packer, M ;
Bristow, MR ;
Gilbert, EM ;
Cohn, JN ;
Fowler, MB ;
Krueger, SK ;
Hershberger, R ;
Uretsky, BF ;
Bowers, JA ;
SacknerBernstein, JD ;
Young, ST ;
Holcslaw, TL ;
Lukas, MA .
CIRCULATION, 1996, 94 (11) :2800-2806
[4]  
Deyo RA, 1991, CONTROLLED CLIN TRIA, V12, P142
[5]   QUALITY-OF-LIFE ON ENALAPRIL AFTER ACUTE MYOCARDIAL-INFARCTION [J].
EKEBERG, O ;
KLEMSDAL, TO ;
KJELDSEN, SE .
EUROPEAN HEART JOURNAL, 1994, 15 (08) :1135-1139
[6]   Surrogate end points in clinical trials: Are we being misled? [J].
Fleming, TR ;
DeMets, DL .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) :605-613
[7]   DEPRESSION FOLLOWING MYOCARDIAL-INFARCTION - IMPACT ON 6-MONTH SURVIVAL [J].
FRASURESMITH, N ;
LESPERANCE, F ;
TALAJIC, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (15) :1819-1825
[8]   DEPRESSION AND 18-MONTH PROGNOSIS AFTER MYOCARDIAL-INFARCTION [J].
FRASURESMITH, N ;
LESPERANCE, F ;
TALAJIC, M .
CIRCULATION, 1995, 91 (04) :999-1005
[9]  
GUYATT GH, 1985, CAN MED ASSOC J, V132, P919
[10]   A CONTROLLED TRIAL OF DIGOXIN IN CONGESTIVE HEART-FAILURE [J].
GUYATT, GH ;
SULLIVAN, MJJ ;
FALLEN, EL ;
TIHAL, H ;
RIDEOUT, E ;
HALCROW, S ;
NOGRADI, S ;
TOWNSEND, M ;
TAYLOR, DW .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (04) :371-375